• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[T3期非小细胞肺癌切除术后的长期结果]

[Long-term results following resection for T3 non-small cell lung cancer].

作者信息

Maniwa Y, Okada M, Yamamoto H

机构信息

Department of Surgery, Kobe University School of Medicine, Japan.

出版信息

Kyobu Geka. 1998 Oct;51(11):939-43.

PMID:9789424
Abstract

Surgical intervention is routinely employed for non-small cell lung cancer, whenever no distant metastasis is found. However, its surgical results depend on the staging of the lung cancer, and surgery for stage III disease is less effective compared with stage I or II disease. For patients with stage III, some treatments such as induction chemotherapy have been tried to support the surgery. Recently, T3 lung cancer is divided in two category of staging, T3N0 is evaluated to be stage II B and T3N1-2 is stage III A. In this study, we classified T3 diseases by some factors, and examined long-term survival of each group. As a result, we concluded that mediastinal invasion and N2 involvement were risk factors to early failure. On the contrary, patients with adjacent lobe invasion and resection of two lobes led to the prolonged survival rather than lobectomy with partial resection of adjacent lobe.

摘要

只要未发现远处转移,手术干预通常用于非小细胞肺癌。然而,其手术结果取决于肺癌的分期,与I期或II期疾病相比,III期疾病的手术效果较差。对于III期患者,已尝试一些治疗方法如诱导化疗来辅助手术。最近,T3期肺癌被分为两个分期类别,T3N0被评估为II B期,T3N1 - 2为III A期。在本研究中,我们根据一些因素对T3期疾病进行分类,并检查每组的长期生存率。结果,我们得出结论,纵隔侵犯和N2受累是早期失败的危险因素。相反,伴有相邻肺叶侵犯且行两肺叶切除的患者比行肺叶切除并部分切除相邻肺叶的患者生存期更长。

相似文献

1
[Long-term results following resection for T3 non-small cell lung cancer].[T3期非小细胞肺癌切除术后的长期结果]
Kyobu Geka. 1998 Oct;51(11):939-43.
2
[Results of resection of T3N0-2M0 non-small cell lung cancer according to involved organ and nodal status].[根据受累器官及淋巴结状态对T3N0 - 2M0期非小细胞肺癌进行切除的结果]
Kyobu Geka. 1998 Oct;51(11):902-6.
3
Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.单中心25年间T4期非小细胞肺癌的初次手术结果:获益值得冒险。
Ann Thorac Surg. 2008 Oct;86(4):1065-75; discussion 1074-5. doi: 10.1016/j.athoracsur.2008.07.004.
4
Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.完全切除的N1期非小细胞肺癌:影响复发和长期生存的因素
J Thorac Cardiovasc Surg. 2006 Sep;132(3):499-506. doi: 10.1016/j.jtcvs.2006.04.019. Epub 2006 Jul 28.
5
Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.非小细胞肺癌袖状肺叶切除术后的发病率、死亡率和长期生存率
Eur J Cardiothorac Surg. 2007 Jan;31(1):95-102. doi: 10.1016/j.ejcts.2006.10.031. Epub 2006 Nov 28.
6
The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.单机构16年间手术切除的IIIA期非小细胞肺癌治疗结果的演变
J Thorac Cardiovasc Surg. 2005 Dec;130(6):1601-10. doi: 10.1016/j.jtcvs.2005.08.010.
7
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.I期非小细胞肺癌亚肺叶切除与肺叶切除的疗效:一项13年的分析。
Ann Thorac Surg. 2006 Aug;82(2):408-15; discussion 415-6. doi: 10.1016/j.athoracsur.2006.02.029.
8
[Results of surgical treatment in patients with T3 non-small cell lung cancer].[T3期非小细胞肺癌患者的外科治疗结果]
Kyobu Geka. 1998 Oct;51(11):921-5.
9
Staging and resection of lung cancer with minimal invasion of the adjacent lobe.肺癌的分期及对相邻肺叶侵袭最小的切除术。
Eur J Cardiothorac Surg. 2007 Dec;32(6):855-8. doi: 10.1016/j.ejcts.2007.09.017. Epub 2007 Nov 1.
10
[Multimodal treatment of non small cell lung cancer].[非小细胞肺癌的多模式治疗]
Zentralbl Chir. 2006 Apr;131(2):110-4. doi: 10.1055/s-2006-921534.